HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Skinvisible marketing deal

This article was originally published in The Rose Sheet

Executive Summary

Firm cancels previously announced agreement with Health First Distributors North America, which included exclusive marketing and distribution rights for Skinvisible 1% triclosan antimicrobial hand sanitizer lotion. Canada-based Health First did not submit a second nonrefundable deposit of $100,000 by Nov. 30, as required by a letter of intent signed Oct. 29, according to Skinvisible. Health First began shipping the product to Walgreens Nov. 12 (1"The Rose Sheet" Nov. 24, 2003, Marketing In Brief)...

You may also be interested in...

Marketing In Brief

Rembrandt: Nighttime Whitening features peroxide gel tooth whitening formula in simple sponge tip applicator system, Den-Mat announces. Sponge applicator turns with click to self-dispense gel on teeth. Gel then forms a "paste-like masque" and dissolves overnight to provide brighter, whiter teeth, according to Den-Mat. Nighttime Whitening is recommended for use alone or in combination with one of Rembrandt's tooth-bleaching kits. The product is available now for $14.95...

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.

venBio Raises $394m To Fund Biopharmas Through Human Proof-Of-Concept

Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts